Target Group Inc. (CBDY)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Target Group Inc. (CBDY) with AI Score 49/100 (Weak). Target Group Inc. cultivates, processes, and distributes cannabis products for the adult-use medical and recreational cannabis market in Canada. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 16, 2026Target Group Inc. (CBDY) Healthcare & Pipeline Overview
Target Group Inc. is a Canadian cannabis company focused on cultivating, processing, and distributing curated cannabis products for the adult-use medical and recreational markets. With a diverse product portfolio including flower, extracts, edibles, and topicals, Target Group aims to capture market share through product innovation and strategic collaborations.
Investment Thesis
Target Group Inc. presents a speculative investment opportunity within the Canadian cannabis market. The company's diverse product portfolio, including innovative offerings like infused beverages and the Wisp vaporizer system, positions it to capture a segment of the adult-use and medical cannabis markets. The collaboration agreement with cGreen, Inc. for True Focus distribution offers potential upside in addressing THC-related side effects. However, the company's negative profit margin of -11.8% and reliance on the OTC market introduce significant risks. Future profitability hinges on successful product launches, effective cost management, and favorable regulatory developments in the cannabis industry. Investors should carefully consider the high beta of 1.49, indicating significant volatility relative to the market.
Based on FMP financials and quantitative analysis
Key Highlights
- Gross Margin of 57.2% indicates strong pricing power and efficient production processes.
- Collaboration agreement with cGreen, Inc. for manufacturing and distributing True Focus, a THC antidote, provides a unique market opportunity.
- Offers Wisp, a single-use pre-measured pod and vaporizer system, catering to consumer demand for convenient cannabis consumption.
- Operates in the Canadian adult-use medical and recreational cannabis market, a rapidly growing sector with increasing consumer acceptance.
- Market capitalization of $0.00B reflects the company's small size and potential for high growth or significant risk.
Competitors & Peers
Strengths
- Diverse product portfolio including flower, extracts, edibles, and topicals.
- Strategic collaborations with cGreen, Inc. and Serious Seeds B.V.
- Proprietary product offerings like the Wisp vaporizer system.
- Presence in the rapidly growing Canadian cannabis market.
Weaknesses
- Negative profit margin of -11.8%.
- Reliance on the OTC market.
- Small market capitalization of $0.00B.
- Limited brand recognition compared to larger competitors.
Catalysts
- Ongoing: Expansion of product line to include new and innovative cannabis products.
- Ongoing: Strategic partnerships and acquisitions to expand market reach.
- Upcoming: Potential regulatory changes in the Canadian cannabis market.
- Ongoing: Increasing consumer demand for CBD wellness products.
- Ongoing: Development of proprietary technology for cultivation and product formulation.
Risks
- Ongoing: Intense competition from established cannabis companies.
- Ongoing: Evolving regulations and changing consumer preferences.
- Potential: Supply chain disruptions.
- Potential: Risk of product recalls or safety concerns.
- Ongoing: Negative profit margin and reliance on the OTC market.
Growth Opportunities
- Expansion of Product Line: Target Group has the opportunity to expand its product line to include new and innovative cannabis products, such as edibles, beverages, and topicals. The market for these products is growing rapidly, and Target Group could capitalize on this trend by developing high-quality, differentiated products. This expansion could target specific consumer segments, such as wellness-focused individuals seeking CBD products or recreational users looking for novel consumption methods. The timeline for this growth opportunity is immediate, with ongoing product development and market testing.
- Strategic Partnerships and Acquisitions: Target Group can pursue strategic partnerships and acquisitions to expand its market reach and product offerings. Partnering with established cannabis companies or acquiring smaller, innovative businesses could provide access to new markets, technologies, and expertise. This strategy could accelerate growth and enhance Target Group's competitive position. The timeline for this growth opportunity is medium-term, requiring careful due diligence and negotiation.
- International Expansion: Target Group could explore opportunities to expand its operations into international markets, particularly in regions where cannabis is legal or decriminalized. This expansion could provide access to new customers and revenue streams. However, international expansion also involves significant risks, such as regulatory compliance and cultural differences. The timeline for this growth opportunity is long-term, requiring careful planning and execution.
- Development of Proprietary Technology: Investing in the development of proprietary technology, such as advanced cultivation techniques or innovative product formulations, could provide Target Group with a competitive advantage. This technology could improve product quality, reduce costs, or create unique product offerings. The timeline for this growth opportunity is medium-term, requiring ongoing research and development efforts.
- Focus on CBD Wellness Products: Target Group can capitalize on the growing demand for CBD wellness products by expanding its offerings in this area. CBD products are increasingly popular for their potential health benefits, and Target Group could develop a range of CBD-infused products targeting specific wellness needs. This strategy could attract a new customer base and generate significant revenue growth. The timeline for this growth opportunity is immediate, with ongoing product development and marketing efforts.
Opportunities
- Expansion of product line to include new and innovative cannabis products.
- Strategic partnerships and acquisitions to expand market reach.
- International expansion into new markets.
- Development of proprietary technology for cultivation and product formulation.
Threats
- Intense competition from established cannabis companies.
- Evolving regulations and changing consumer preferences.
- Potential for supply chain disruptions.
- Risk of product recalls or safety concerns.
Competitive Advantages
- Established presence in the Canadian cannabis market.
- Diverse product portfolio catering to various consumer preferences.
- Strategic collaborations and licensing agreements.
- Proprietary product offerings like the Wisp vaporizer system.
About CBDY
Target Group Inc., formerly Chess Supersite Corporation, was incorporated in 2013 and rebranded in July 2018 to focus on the burgeoning cannabis market. Based in Hamilton, Canada, the company cultivates, processes, and distributes a range of cannabis products for the adult-use medical and recreational sectors. Their product line includes cannabis flower, extract pods for vaporizers, pre-rolls, k-cup infused coffee and tea pods, infused beverages and edibles, topical products, and CBD wellness products. A key offering is the Wisp, a single-use pre-measured pod and vaporizer system designed for vaporizing natural herbs, including cannabis. Target Group has established strategic collaborations, including an agreement with cGreen, Inc. to manufacture and distribute the THC antidote True Focus in the United States, Europe, and the Caribbean. They also have a distribution, collaboration, and licensing agreement with Serious Seeds B.V., further expanding their market reach and product offerings. With 41 employees, Target Group is positioning itself to capitalize on the growing demand for diverse and innovative cannabis products in the Canadian market.
What They Do
- Cultivates cannabis plants for the adult-use medical and recreational markets.
- Processes raw cannabis into various product formats.
- Distributes cannabis products to retailers and consumers in Canada.
- Manufactures cannabis flower and extract pods for vaporizer use.
- Produces cannabis pre-rolls for convenient consumption.
- Creates k-cup infused coffee and tea pods with cannabis.
- Develops and sells infused cannabis beverages and edibles.
- Offers infused topical products and CBD wellness products.
Business Model
- Cultivation and processing of cannabis plants.
- Manufacturing and distribution of cannabis products.
- Revenue generation through product sales to retailers and consumers.
- Strategic collaborations and licensing agreements to expand market reach.
Industry Context
The Canadian cannabis market is experiencing substantial growth, driven by increasing legalization and consumer acceptance. Companies like Target Group Inc. operate in a competitive landscape that includes both large, established players and smaller, niche-focused businesses. The market is characterized by evolving regulations, product innovation, and increasing demand for diverse cannabis products. Target Group's focus on curated products and strategic collaborations positions it to capture a share of this expanding market, but it faces competition from companies such as ALID, BINP, BMMJ, CPMD, and EXMT, all vying for market share.
Key Customers
- Adult-use recreational cannabis consumers.
- Medical cannabis patients with prescriptions.
- Retailers and dispensaries selling cannabis products.
- Consumers seeking CBD wellness products.
Financials
Chart & Info
Target Group Inc. (CBDY) stock price: Price data unavailable
Latest News
-
Stocks That Hit 52-Week Lows On Monday
· Feb 10, 2020
-
Stocks That Hit 52-Week Lows On Thursday
· Nov 14, 2019
-
Stocks That Hit 52-Week Lows On Tuesday
· Oct 1, 2019
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CBDY.
Price Targets
Wall Street price target analysis for CBDY.
MoonshotScore
What does this score mean?
The MoonshotScore rates CBDY's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Anthony Carlo Zarcone
CEO
Anthony Carlo Zarcone is the CEO of Target Group Inc., leading a team of 41 employees. Information regarding his detailed career history and educational background is not available in the provided data. As CEO, he is responsible for the overall strategic direction and operational management of the company, guiding its efforts in the cultivation, processing, and distribution of cannabis products in the Canadian market.
Track Record: Specific achievements and milestones under Anthony Carlo Zarcone's leadership are not detailed in the provided data. However, as CEO, he has overseen the company's focus on developing a diverse product portfolio, including innovative offerings like the Wisp vaporizer system, and establishing strategic collaborations with companies like cGreen, Inc. and Serious Seeds B.V.
CBDY OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Target Group Inc. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting, making it more difficult for investors to assess their financial health and operational performance. Investing in companies on the OTC Other tier carries a higher degree of risk compared to those listed on major exchanges like the NYSE or NASDAQ.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases the difficulty of assessing the company's financial health.
- Low trading volume and wide bid-ask spreads can lead to price volatility and difficulty in executing trades.
- Higher risk of fraud or manipulation compared to companies listed on major exchanges.
- OTC Other tier status indicates the company may not meet minimum financial standards.
- Potential for delisting or suspension of trading due to non-compliance with OTC regulations.
- Verify the company's registration and compliance with regulatory requirements.
- Review available financial statements and assess the company's financial health.
- Research the company's management team and their track record.
- Understand the company's business model and competitive landscape.
- Assess the liquidity of the stock and the potential for price volatility.
- Consult with a financial advisor before making any investment decisions.
- Check for any legal or regulatory issues involving the company.
- Established presence in the Canadian cannabis market.
- Diverse product portfolio catering to various consumer preferences.
- Strategic collaborations with cGreen, Inc. and Serious Seeds B.V.
- Company has been in operation since 2013.
CBDY Healthcare Stock FAQ
What does Target Group Inc. do?
Target Group Inc. is a Canadian cannabis company focused on cultivating, processing, and distributing curated cannabis products for the adult-use medical and recreational markets. The company offers a diverse range of products, including cannabis flower, extract pods for vaporizers, pre-rolls, infused beverages and edibles, topical products, and CBD wellness products. Target Group also offers the Wisp, a single-use pre-measured pod and vaporizer system. The company aims to differentiate itself through product innovation and strategic collaborations, such as its agreements with cGreen, Inc. and Serious Seeds B.V.
What do analysts say about CBDY stock?
There is no analyst coverage information available in the provided data. As such, there is no analyst consensus, valuation metrics, or growth considerations to summarize. Investors should conduct their own independent research and due diligence before making any investment decisions regarding CBDY stock. The lack of analyst coverage may reflect the company's small size and OTC market listing.
What are the main risks for CBDY?
Target Group Inc. faces several risks, including intense competition from established cannabis companies, evolving regulations and changing consumer preferences in the cannabis market, and potential supply chain disruptions. The company's negative profit margin and reliance on the OTC market also pose significant risks. Additionally, there is a risk of product recalls or safety concerns, which could damage the company's reputation and financial performance. Investors should carefully consider these risks before investing in CBDY.
What are the key factors to evaluate for CBDY?
Target Group Inc. (CBDY) currently holds an AI score of 49/100, indicating low score. Key strength: Diverse product portfolio including flower, extracts, edibles, and topicals.. Primary risk to monitor: Ongoing: Intense competition from established cannabis companies.. This is not financial advice.
How frequently does CBDY data refresh on this page?
CBDY prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven CBDY's recent stock price performance?
Recent price movement in Target Group Inc. (CBDY) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Diverse product portfolio including flower, extracts, edibles, and topicals.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider CBDY overvalued or undervalued right now?
Determining whether Target Group Inc. (CBDY) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying CBDY?
Before investing in Target Group Inc. (CBDY), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on CEO's background and track record.
- Disclosure status on OTC markets is unknown, increasing investment risk.